Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab

A severe and persistent migrainous headache in a patient with primary Sjøgren's syndrome unresponsive to treatment with immunosuppressive drugs, triptans, opioids, and NSAIDs, responded successfully to intrathecal B‐cell depletion with rituximab. We hypothesize that brain‐resident autoreactive...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjensvoll, Anne Bolette, Lauvsnes, Maria Boge, Norheim, Katrine Brekke, Omdal, Roald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406134/
https://www.ncbi.nlm.nih.gov/pubmed/30899462
http://dx.doi.org/10.1002/ccr3.1987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406134/
https://www.ncbi.nlm.nih.gov/pubmed/30899462
http://dx.doi.org/10.1002/ccr3.1987

Ejemplares similares